Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29339720
Publication Date : //

Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.


Esophageal squamous cell carcinoma (ESCC) is one of the deadliest cancers, and it requires novel treatment approaches and effective drugs. In the present study, we found that treatment with plumbagin, a natural compound, reduced proliferation and survival of the KYSE150 and KYSE450 ESCC cell lines in a dose-dependent manner in vitro. The drug also effectively inhibited the viability of primary ESCC cells from fresh biopsy specimens. Furthermore, plumbagin-induced mitotic arrest and massive apoptosis in ESCC cells. Notably, the drug significantly suppressed the colony formation capacity of ESCC cells in vitro and the growth of KYSE150 xenograft tumors in vivo. At the molecular level, we found that exposure to plumbagin decreased both polo-like kinase 1 (PLK1) and phosphorylated protein kinase B (p-AKT) expression in both ESCC cell lines. Enforced PLK1 expression in ESCC cells not only markedly rescued cells from plumbagin-induced apoptosis and proliferation inhibition but also restored the impaired AKT activity. Furthermore, signal transducer and activator of transcription 3 (STAT3), a transcription factor of PLK1, was also inactivated in plumbagin-treated ESCC cells; however, the overexpression of a constitutively activated STAT3 mutant, STAT3C, reinstated the plumbagin-elicited blockade of PLK1-AKT signaling in ESCC cells. Taken together, these findings indicate that plumbagin inhibits proliferation and potentiates apoptosis in human ESCC cells in vitro and in vivo. Plumbagin may exert these antitumor effects by abrogating STAT3-PLK1-AKT signaling, which suggests that plumbagin may be a novel, promising anticancer agent for the treatment of ESCC.

Authors : Cao Ying-Ya , Yu Jing , Liu Ting-Ting , Yang Kai-Xia , Yang Li-Yan , Chen Qun , Shi Feng , Hao Jia-Jie , Cai Yan , Wang Ming-Rong , Lu Wei-Hua , Zhang Yu ,

Related products :

Catalog number Product name Quantity
GI_Esophagus - ESC961 Esophageal cancer array consists of duplicated 36 cases of esophageal cancer and 12 cases of normal and other non_malignant esophageal tissues. 1.5mm
orb84786 IL4 protein Interleukin4 is a pleiotropic cytokine that regulates diverse T and B cell responses including cell proliferation, survival and gene expression. Produced by mast cells, T cells and bone ma 20
orb84821 IL4 protein Interleukin4 is a pleiotropic cytokine that regulates diverse T and B cell responses including cell proliferation, survival and gene expression. Produced by mast cells, T cells and bone ma 10
orb82806 Mouse IL4 protein Interleukin-4 is a pleiotropic cytokine that regulates diverse T and B cell responses including cell proliferation, survival and gene expression. Produced by mast cells, T cells and 1 mg
677 Esophageal mucous chronic inflammation, esophageal intraepithelial neoplasia, esophageal cancer tissue array, including TNM, clinical stage and pathology grade, 60cases_ 120cores,
30-121 C21orf33 inhibits both estrogen- and heregulin-beta1-stimulated growth of breast cancer cells, and further suggests that growth inhibition induced in these cells by all-trans retinoic acid occurs via 0.1 mg
GI_Esophagus - ESC1501 Esophageal cancer array consists of duplicated 70 cases of esophageal cancers of different grades and stages, and 5 cases of normal and other non_malignant esophageal tissues. 1.1 mm
9-47024 Human Cancer PrimaCell™1: Esophageal Tumor Cells, primary cell culture set
4-28024 Human Cancer PrimaCell™1: Esophageal Tumor Cells, primary cell culture Kit
9-47030 Human Cancer PrimaCell™7: Esophageal Tumor Cells, primary cell culture set
9-80024 Human Cancer PrimaCell™1: Esophageal Tumor Cells, primary cell culture 1 x 100 ml
9-80030 Human Cancer PrimaCell™7: Esophageal Tumor Cells, primary cell culture 1 x 100 ml
4-28030 Human Cancer PrimaCell™7: Esophageal Tumor Cells, primary cell culture Kit
2-96030 Human Cancer PrimaCell™7: Esophageal Tumor Cells, primary cell culture Kit
9-46030 Human Cancer PrimaCell™7: Esophageal Tumor Cells, primary cell culture 5 x 100 ml
2-96024 Human Cancer PrimaCell™1: Esophageal Tumor Cells, primary cell culture Kit
9-46024 Human Cancer PrimaCell™1: Esophageal Tumor Cells, primary cell culture 5 x 100 ml
orb84810 VEGF165 protein VEGF is a potent growth and angiogenic cytokine. It stimulates proliferation and survival of endothelial cells, and promotes angiogenesis and vascular permeability. Expressed in vascul 10
orb82804 Mouse IL3 protein Recombinant Mouse Interleukin-3 (IL3) is a hematopoietic growth factor that promotes the survival, differentiation and proliferation of committed progenitor cells of the megakaryocyt 1 mg
ES809 Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases_80 cores
30-711 In vitro study revealed that RSRC2 might play a role in cell proliferation. RSRC2 may be a novel tumor suppressor of esophageal cancer cell growth. 0.1 mg
ES809 Esophageal disease spectrum (esophageal cancer progression) tissue array, 78 cases_80 cores; ihc Anti-Actin confirmed
31-070 HSP90AB1 is an isoform of the hsp90 family. It is expressed in cancer cells, but not associated with cell proliferation. 0.1 mg
orb82687 Human EMAP 2 protein EMAP 2 is a tumor derived cytokine that exerts a wide range of activities on endothelial cells, monocytes and neutrophils. EMAP-II inhibits endothelial cell proliferation, vasculo 1 mg
Z7020029 Esophageal Tumor Tissue Array _ Duplicated 36 cases of esophageal cancer and 12 cases of normal and other non_malignant 5 slides


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur